CA2499412A1 - Procede de calcul permettant de predire des interactions intramoleculaires et intermoleculaires entre des biopolymeres - Google Patents
Procede de calcul permettant de predire des interactions intramoleculaires et intermoleculaires entre des biopolymeres Download PDFInfo
- Publication number
- CA2499412A1 CA2499412A1 CA002499412A CA2499412A CA2499412A1 CA 2499412 A1 CA2499412 A1 CA 2499412A1 CA 002499412 A CA002499412 A CA 002499412A CA 2499412 A CA2499412 A CA 2499412A CA 2499412 A1 CA2499412 A1 CA 2499412A1
- Authority
- CA
- Canada
- Prior art keywords
- scores
- sequence
- misaligned
- data
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003993 interaction Effects 0.000 title claims abstract description 99
- 229920001222 biopolymer Polymers 0.000 title claims abstract description 60
- 238000000205 computational method Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 416
- 230000008569 process Effects 0.000 claims abstract description 156
- 238000002864 sequence alignment Methods 0.000 claims abstract description 63
- 238000012216 screening Methods 0.000 claims abstract description 46
- 230000009878 intermolecular interaction Effects 0.000 claims abstract description 12
- 230000008863 intramolecular interaction Effects 0.000 claims abstract description 8
- 238000009826 distribution Methods 0.000 claims description 44
- 238000013077 scoring method Methods 0.000 claims description 14
- 238000007619 statistical method Methods 0.000 claims description 12
- 238000003379 elimination reaction Methods 0.000 claims description 9
- 230000004001 molecular interaction Effects 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 5
- 238000000342 Monte Carlo simulation Methods 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 61
- 102000004169 proteins and genes Human genes 0.000 abstract description 59
- 238000013459 approach Methods 0.000 abstract description 31
- 230000003044 adaptive effect Effects 0.000 abstract description 3
- 238000007670 refining Methods 0.000 abstract description 3
- 238000005065 mining Methods 0.000 abstract description 2
- 238000010348 incorporation Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 54
- 238000004458 analytical method Methods 0.000 description 29
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 27
- 238000004422 calculation algorithm Methods 0.000 description 19
- 230000035772 mutation Effects 0.000 description 17
- 238000004364 calculation method Methods 0.000 description 16
- 239000013078 crystal Substances 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 15
- 230000000875 corresponding effect Effects 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 102000039446 nucleic acids Human genes 0.000 description 14
- 108020004707 nucleic acids Proteins 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 14
- 108020004566 Transfer RNA Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 108090000994 Catalytic RNA Proteins 0.000 description 8
- 102000053642 Catalytic RNA Human genes 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 101150053343 NAD5 gene Proteins 0.000 description 8
- 238000007405 data analysis Methods 0.000 description 8
- 108091092562 ribozyme Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 101150071146 COX2 gene Proteins 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 108010010369 HIV Protease Proteins 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 230000002939 deleterious effect Effects 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- 241000220225 Malus Species 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 102000004167 Ribonuclease P Human genes 0.000 description 3
- 108090000621 Ribonuclease P Proteins 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000007418 data mining Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000000710 homodimer Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000000869 mutational effect Effects 0.000 description 3
- 230000004850 protein–protein interaction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 2
- 108010059013 Chaperonin 10 Proteins 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 238000007476 Maximum Likelihood Methods 0.000 description 2
- 241000039733 Thermoproteus thermophilus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 101150038923 atpF gene Proteins 0.000 description 2
- 101150105110 atpF2 gene Proteins 0.000 description 2
- 101150018639 atpFH gene Proteins 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012067 mathematical method Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000006916 protein interaction Effects 0.000 description 2
- 238000000455 protein structure prediction Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000037432 silent mutation Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 description 1
- ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101100095803 Bacillus subtilis (strain 168) sigW gene Proteins 0.000 description 1
- 101100378273 Brachyspira hyodysenteriae acpP gene Proteins 0.000 description 1
- 101100439426 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) groEL4 gene Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101100446326 Caenorhabditis elegans fbxl-1 gene Proteins 0.000 description 1
- 101100266755 Cyanidium caldarium ycf39 gene Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000029746 Histidine-tRNA Ligase Human genes 0.000 description 1
- 101710177011 Histidine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101100098690 Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) hly gene Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- SLEHROROQDYRAW-KQYNXXCUSA-N N(2)-methylguanosine Chemical compound C1=NC=2C(=O)NC(NC)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O SLEHROROQDYRAW-KQYNXXCUSA-N 0.000 description 1
- 101150036433 NAD3 gene Proteins 0.000 description 1
- 101150093297 NAD4 gene Proteins 0.000 description 1
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 101710096715 Probable histidine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 238000000505 RNA structure prediction Methods 0.000 description 1
- 230000010799 Receptor Interactions Effects 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 108010070663 Transposon Resolvases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 101150077981 groEL gene Proteins 0.000 description 1
- 101150021605 hlyA gene Proteins 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000008073 immune recognition Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 101150017854 petB gene Proteins 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000012066 statistical methodology Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 101150008351 ycf3 gene Proteins 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioethics (AREA)
- Genetics & Genomics (AREA)
- Artificial Intelligence (AREA)
- Molecular Biology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
L'invention concerne un procédé de calcul permettant de prédire des interactions intramoléculaires et intermoléculaires entre des biopolymères, qui consiste en une manière améliorée de déterminer une structure et des informations de fonction, ces interactions intramoléculaires et intermoléculaires utilisant une approche du type ab initio, c'est-à-dire utilisant uniquement des informations de séquence. Ledit procédé peut largement s'appliquer à un outil d'exploitation de séquence capable de détecter à la fois des interactions intramoléculaires et des interactions intermoléculaires pour tous les biopolymères, notamment, un ADN, un ARN et une protéine. Il inclue un processus de criblage adaptatif permettant d'obtenir une précision élevée. Il peut consister en une méthodologie totalement sans de règles et impartiale, et permet donc de détecter de nouvelles interactions pour tous les biopolymères. Du fait de l'incorporation d'un processus de désalignement, ledit procédé peut s'utiliser de manière itérative, et est capable de redéfinir ses propres prédictions et de détecter et de gérer des erreurs. Le procédé décrit peut également fournir une technique permettant de déterminer de manière plus précise (et de redéfinir) des alignements de séquences.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/030656 WO2004027540A2 (fr) | 2002-09-23 | 2002-09-23 | Procede de calcul permettant de predire des interactions intramoleculaires et intermoleculaires entre des biopolymeres |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2499412A1 true CA2499412A1 (fr) | 2004-04-01 |
Family
ID=32028467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002499412A Abandoned CA2499412A1 (fr) | 2002-09-23 | 2002-09-23 | Procede de calcul permettant de predire des interactions intramoleculaires et intermoleculaires entre des biopolymeres |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002334688A1 (fr) |
CA (1) | CA2499412A1 (fr) |
WO (1) | WO2004027540A2 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993001484A1 (fr) * | 1991-07-11 | 1993-01-21 | The Regents Of The University Of California | Methode permettant d'identifier des sequences de proteines qui se plient pour former une structure en trois dimensions connue |
US5453937A (en) * | 1993-04-28 | 1995-09-26 | Immunex Corporation | Method and system for protein modeling |
US5878373A (en) * | 1996-12-06 | 1999-03-02 | Regents Of The University Of California | System and method for determining three-dimensional structure of protein sequences |
-
2002
- 2002-09-23 WO PCT/US2002/030656 patent/WO2004027540A2/fr not_active Application Discontinuation
- 2002-09-23 CA CA002499412A patent/CA2499412A1/fr not_active Abandoned
- 2002-09-23 AU AU2002334688A patent/AU2002334688A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004027540A2 (fr) | 2004-04-01 |
WO2004027540A3 (fr) | 2005-03-24 |
AU2002334688A1 (en) | 2004-04-08 |
AU2002334688A8 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wolfe et al. | Systematic survey reveals general applicability of" guilt-by-association" within gene coexpression networks | |
US8504498B2 (en) | Method of generating an optimized, diverse population of variants | |
Simons et al. | Prospects for ab initio protein structural genomics | |
Karchin et al. | Hidden Markov models that use predicted local structure for fold recognition: alphabets of backbone geometry | |
Hosack et al. | Identifying biological themes within lists of genes with EASE | |
US10155943B2 (en) | Method of generating an optimized, diverse population of variants | |
Wang et al. | How good is prediction of protein structural class by the component‐coupled method? | |
Liu et al. | The number of protein folds and their distribution over families in nature | |
US20150065357A1 (en) | Methods, systems, and software for identifying functional bio-molecules | |
US20020095260A1 (en) | Methods for efficiently mining broad data sets for biological markers | |
AU2012328864A1 (en) | Selection of preferred sample handling and processing protocol for identification of disease biomarkers and sample quality assessment | |
Tetko et al. | Super paramagnetic clustering of protein sequences | |
Friedberg et al. | Using an alignment of fragment strings for comparing protein structures | |
Bostick et al. | A simple topological representation of protein structure: implications for new, fast, and robust structural classification | |
Ding et al. | A survey of SNP data analysis | |
Marcotte et al. | Exploiting big biology: integrating large-scale biological data for function inference | |
US20050026145A1 (en) | Computational method for predicting intramolecular and intermolecular biopolymer interactions | |
Zhang et al. | iSP-RAAC: Identify secretory proteins of malaria parasite using reduced amino acid composition | |
Xi et al. | SiftCell: A robust framework to detect and isolate cell-containing droplets from single-cell RNA sequence reads | |
CA2499412A1 (fr) | Procede de calcul permettant de predire des interactions intramoleculaires et intermoleculaires entre des biopolymeres | |
Bell et al. | MIPHENO: data normalization for high throughput metabolite analysis | |
Eblen et al. | Graph algorithms for integrated biological analysis, with applications to type 1 diabetes data | |
Kennedy et al. | General strategies for using amino acid sequence data to guide biochemical investigation of protein function | |
Xiao et al. | Using cellular automata images to predict protein structural classes | |
Rajasekaran | Computational techniques for motif search |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |